EIF-4E and EIF-4A circulating levels, critical regulators of gene translation and protein functions, may be targets for intervention by repurposing existing therapeutics to reduce the risk of type 2 diabetes. This evidence concerns the gene EIF4E and type 2 diabetes mellitus.